Nektar Therapeutics
NKTR
Nektar Therapeutics (NKTR) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Neutral | $65.00 | Aug 21, 2026 |
| Canaccord Genuity | Initiated Coverage | Buy | $153.00 | Jul 22, 2026 |
| Wedbush | Maintained | Neutral | $80.00 from $95.00 | May 11, 2026 |
| Piper Sandler | Maintained | Overweight | $192.00 from $105.00 | May 8, 2026 |
| Wedbush | Maintained | Neutral | $95.00 from $70.00 | Apr 21, 2026 |
| Citigroup | Maintained | Buy | $151.00 from $123.00 | Apr 21, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $185.00 from $165.00 | Apr 20, 2026 |
| BTIG | Maintained | Buy | $178.00 from $151.00 | Apr 20, 2026 |
| Wedbush | Initiated Coverage | Neutral | $70.00 | Mar 24, 2026 |
| TD Cowen | Initiated Coverage | Buy | — | Mar 17, 2026 |
| Citigroup | Maintained | Buy | $123.00 from $102.00 | Mar 16, 2026 |
| B. Riley Securities | Maintained | Buy | $150.00 from $105.00 | Feb 23, 2026 |
| BTIG | Maintained | Buy | $151.00 from $118.00 | Feb 10, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $165.00 from $135.00 | Feb 10, 2026 |
| BTIG | Maintained | Buy | $118.00 | Jan 29, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $135.00 from $120.00 | Dec 16, 2025 |
| BTIG | Maintained | Buy | $118.00 from $100.00 | Dec 16, 2025 |
| Jefferies | Maintained | Buy | $121.00 from $99.00 | Nov 26, 2025 |
| Citigroup | Initiated Coverage | Buy | $102.00 | Nov 26, 2025 |
| B. Riley Securities | Maintained | Buy | $105.00 from $85.00 | Sep 23, 2025 |
Frequently asked questions
What is the latest analyst rating on NKTR?
On Aug 21, 2026, JP Morgan maintained Nektar Therapeutics at Neutral with a price target of $65.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.